Nan Du

Phase II, Open-Label, Single-Arm Trial of Imatinib Mesylate in Patients With Metastatic Melanoma Harboring <i>c-Kit</i> Mutation or Amplification

Jun Guo, Lu Si, Yan Kong et al. · Journal of Clinical Oncology · 2011 · 673 citations · Full text

Dysbiosis of maternal and neonatal microbiota associated with gestational diabetes mellitus

Jinfeng Wang, Jiayong Zheng, Wenyu Shi et al. · Gut · 2018 · 437 citations · Full text

Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancer-mediated malignant pleural effusion

Nan Du, Xiaosong Li, Fang Li et al. · Oncology Reports · 2013 · 87 citations · Full text

TP53 Mutation as Potential Negative Predictor for Response of Anti-CTLA-4 Therapy in Metastatic Melanoma

Wenjing Xiao, Nan Du, Taoyuan Huang et al. · EBioMedicine · 2018 · 83 citations · Full text

Macrophage migration inhibitory factor facilitates prostaglandin E2 production of astrocytes to tune inflammatory milieu following spinal cord injury

Yuxin Zhang, Yue Zhou, Shuxia Chen et al. · Journal of Neuroinflammation · 2019 · 72 citations · Full text